Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA–DRB1*0405 and *0901
Hye-Soon Lee
Hanyang University College of Medicine, Hospital for Rheumatic Diseases, Seoul, South Korea
Drs. Hye-Soon Lee and Kyung Wha Lee contributed equally to this work.
Search for more papers by this authorKyung Wha Lee
Hallym Institution for Genome Application, Hallym University Sacred Heart Hospital, Anyang, South Korea
Drs. Hye-Soon Lee and Kyung Wha Lee contributed equally to this work.
Search for more papers by this authorGwan Gyu Song
College of Medicine, Korea University, Seoul, South Korea
Search for more papers by this authorHyun-Ah Kim
Hallym University Kangdong Sacred Heart Hospital, Seoul, South Korea
Search for more papers by this authorShin-Yoon Kim
Kyungpook National University College of Medicine, Daegu, South Korea
Search for more papers by this authorCorresponding Author
Sang-Cheol Bae
Hanyang University College of Medicine, Hospital for Rheumatic Diseases, Seoul, South Korea
Hospital for Rheumatic Diseases, Hanyang University Medical Center, Seoul 133-792, South KoreaSearch for more papers by this authorHye-Soon Lee
Hanyang University College of Medicine, Hospital for Rheumatic Diseases, Seoul, South Korea
Drs. Hye-Soon Lee and Kyung Wha Lee contributed equally to this work.
Search for more papers by this authorKyung Wha Lee
Hallym Institution for Genome Application, Hallym University Sacred Heart Hospital, Anyang, South Korea
Drs. Hye-Soon Lee and Kyung Wha Lee contributed equally to this work.
Search for more papers by this authorGwan Gyu Song
College of Medicine, Korea University, Seoul, South Korea
Search for more papers by this authorHyun-Ah Kim
Hallym University Kangdong Sacred Heart Hospital, Seoul, South Korea
Search for more papers by this authorShin-Yoon Kim
Kyungpook National University College of Medicine, Daegu, South Korea
Search for more papers by this authorCorresponding Author
Sang-Cheol Bae
Hanyang University College of Medicine, Hospital for Rheumatic Diseases, Seoul, South Korea
Hospital for Rheumatic Diseases, Hanyang University Medical Center, Seoul 133-792, South KoreaSearch for more papers by this authorAbstract
Objective
To investigate the association of susceptibility and protective HLA–DRB1 alleles with rheumatoid arthritis (RA) and its clinical markers in an Asian population.
Methods
All RA patients (n = 574) and control subjects (n = 392) were Korean. HLA–DRB1 typing and further subtyping of all alleles was performed by polymerase chain reaction, sequence-specific oligonucleotide probe hybridization, and direct DNA sequencing analysis. We used a relative predispositional effects (RPEs) method and a false discovery rate correction method for multiple comparisons.
Results
The DRB1*0405 and *0901 alleles showed the most significant associations with RA (P = 7.83 × 10−24, odds ratio [OR] 4.40 [95% confidence interval (95% CI) 3.24–5.99], and P = 3.76 × 10−9, OR 2.47 [95% CI 1.82–3.36], respectively). The RPEs test showed that the DRB1*0401 and *0410 alleles conferred susceptibility and that the DRB1*0701, *0802, *1301, *1302, *1403, and *1405 alleles showed significant protective effects. Susceptibility and protective alleles both showed a pattern consistent with additive genetic effects, and each influenced RA independently of the other. The compound heterozygote DRB1*0405/*0901 was associated with the highest risk of RA (corrected P = 1.81 × 10−11, OR 58.2 [95% CI 7.95–425.70]). The mean age at disease onset was ∼4 years earlier or was 3 years earlier, respectively, in patients with at least 1 copy of the DRB1*0405 or the DRB1*0901 allele. Radiographic changes (stages II–IV) were more frequent in patients with at least 1 copy of DRB1*0405 (P = 0.032, 92.6% versus 84.3%, OR 2.33 [95% CI 1.24–4.39]).
Conclusion
The DRB1*0405/*0901 heterozygote has the strongest association with RA, suggesting that this heterozygote enhances the susceptibility to RA in Koreans.
REFERENCES
- 1 MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000; 43: 30–7.
- 2 Shiozawa S, Hayashi S, Tsukamoto Y, Goko H, Kawasaki H, Wada T, et al. Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol 1998; 10: 1891–5.
- 3 MacKay K, Eyre S, Myerscough A, Milicic A, Barton A, Laval S, et al. Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum 2002; 46: 632–9.
- 4 Balsa A, Barrera P, Westhovens R, Alves H, Maenaut K, Pascual-Salcedo D, et al. Clinical and immunogenetic characteristics of European multicase rheumatoid arthritis families. Ann Rheum Dis 2001; 60: 573–6.
- 5 Takeuchi F, Mori M, Goto M, Matsuta K, Yamada A, Chihara T, et al. Mode of inheritance of HLA-DRB1 shared epitope in Japanese familial rheumatoid arthritis. Clin Exp Rheumatol 2002; 20: 395–8.
- 6 Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Monteiro J, et al. A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 2001; 68: 927–36.
- 7 Cornelis F, Faure S, Martinez M, Prud'homme JF, Fritz P, Dib C, et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A 1998; 95: 10746–50.
- 8 Cox A, Camp NJ, Cannings C, di Giovine FS, Dale M, Worthington J, et al. Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis. Hum Mol Genet 1999; 8: 1707–13.
- 9 Fife MS, Fisher SA, John S, Worthington J, Shah CJ, Ollier WE, et al. Multipoint linkage analysis of a candidate gene locus in rheumatoid arthritis demonstrates significant evidence of linkage and association with the corticotropin-releasing hormone genomic region. Arthritis Rheum 2000; 43: 1673–8.
- 10 Moroldo MB, Donnelly P, Saunders J, Glass DN, Giannini EH. Transmission disequilibrium as a test of linkage and association between HLA alleles and pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 1998; 41: 1620–4.
- 11 De Vries N, Tijssen H, van Riel PL, van de Putte LB. Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67–74 of the HLA–DRB1 molecule. Arthritis Rheum 2002; 46: 921–8.
- 12 Benazet JF, Reviron D, Mercier P, Roux H, Roudier J. HLA-DRB1 alleles associated with rheumatoid arthritis in southern France: absence of extraarticular disease despite expression of the shared epitope. J Rheumatol 1995; 22: 607–10.
- 13 Jawaheer D, Thomson W, MacGregor AJ, Carthy D, Davidson J, Dyer PA, et al. “Homozygosity” for the HLA–DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum 1994; 37: 681–6.
- 14 Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205–13.
- 15 Stastny P. Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest 1976; 57: 1148–57.
- 16 Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978; 298: 869–71.
- 17 Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci U S A 1989; 86: 10049–53.
- 18 Templin DW, Boyer GS, Lanier AP, Nelson JL, Barrington RA, Hansen JA, et al. Rheumatoid arthritis in Tlingit Indians: clinical characterization and HLA associations. J Rheumatol 1994; 21: 1238–44.
- 19 Williams RC, Jacobsson LT, Knowler WC, del Puente A, Kostyu D, McAuley JE, et al. Meta-analysis reveals association between most common class II haplotype in full-heritage Native Americans and rheumatoid arthritis. Hum Immunol 1995; 42: 90–4.
- 20 Schiff B, Mizrachi Y, Orgad S, Yaron M, Gazit E. Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. Ann Rheum Dis 1982; 41: 403–4.
- 21 Gao X, Gazit E, Livneh A, Stastny P. Rheumatoid arthritis in Israeli Jews: shared sequences in the third hypervariable region of DRB1 alleles are associated with susceptibility. J Rheumatol 1991; 18: 801–3.
- 22 De Vries N, Ronningen KS, Tilanus MG, Bouwens-Rombouts A, Segal R, Egeland T, et al. HLA-DR1 and rheumatoid arthritis in Israeli Jews: sequencing reveals that DRB1*0102 is the predominant HLA-DR1 subtype. Tissue Antigens 1993; 41: 26–30.
- 23 Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS. HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks: the HLA–DRβ shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum 1992; 35: 749–55.
- 24 Sanchez B, Moreno I, Magarino R, Garzon M, Gonzalez MF, Garcia A, et al. HLA-DRw10 confers the highest susceptibility to rheumatoid arthritis in a Spanish population. Tissue Antigens 1990; 36: 174–6.
- 25 Kim TG, Choi HB, Park SH, Kim HY, Han H. DQCAR 113 and DQCAR 115 in combination with HLA-DRB1 alleles are significant markers of susceptibility to rheumatoid arthritis in the Korean population. Tissue Antigens 1999; 54: 552–9.
- 26 Kim HY, Min JK, Yang HI, Park SH, Hong YS, Jee WH, et al. The impact of HLA-DRB1*0405 on disease severity in Korean patients with seropositive rheumatoid arthritis. Br J Rheumatol 1997; 36: 440–3.
- 27 Hong GH, Park MH, Takeuchi F, Oh MD, Song YW, Nabeta H, et al. Association of specific amino acid sequence of HLA-DR with rheumatoid arthritis in Koreans and its diagnostic value. J Rheumatol 1996; 23: 1699–703.
- 28 Kim HY, Kim TG, Park SH, Lee SH, Cho CS, Han H. Predominance of HLA-DRB1*0405 in Korean patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54: 988–90.
- 29 Wakitani S, Murata N, Toda Y, Ogawa R, Kaneshige T, Nishimura Y, et al. The relationship between HLA-DRB1 alleles and disease subsets of rheumatoid arthritis in Japanese. Br J Rheumatol 1997; 36: 630–6.
- 30 Zhao Y, Dong Y, Zhu X, Qiu C. HLA-DRB1 alleles genotyping in patients with rheumatoid arthritis in Chinese. Chin Med Sci J 1996; 11: 232–5.
- 31 Gonzalez A, Nicovani S, Massardo L, Bull P, Rodriguez L, Jacobelli S. Novel genetic markers of rheumatoid arthritis in Chilean patients, by DR serotyping and restriction fragment length polymorphism analysis. Arthritis Rheum 1992; 35: 282–9.
- 32 Wakitani S, Imoto K, Murata N, Toda Y, Ogawa R, Ochi T. The homozygote of HLA-DRB1*0901, not its heterozygote, is associated with rheumatoid arthritis in Japanese. Scand J Rheumatol 1998; 27: 381–2.
- 33 Milicic A, Lee D, Brown MA, Darke C, Wordsworth BP. HLA-DR/DQ haplotype in rheumatoid arthritis: novel allelic associations in UK Caucasians. J Rheumatol 2002; 29: 1821–6.
- 34 Mattey DL, Hassell AB, Plant MJ, Cheung NT, Dawes PT, Jones PW, et al. The influence of HLA-DRB1 alleles encoding the DERAA amino acid motif on radiological outcome in rheumatoid arthritis. Rheumatology (Oxford) 1999; 38: 1221–7.
- 35 Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24.
- 36 Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992; 35: 498–502.
- 37 Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659–62.
- 38 Bignon JD, Fernandez-Vina MA. Protocols of the 12th International Histocompatibility Workshop for typing of HLA class II alleles by DNA amplification by the polymerase chain reaction (PCR) and hybridization with sequence specific oligonucleotide probes (SSOP). In: D Charron, editor. Genetic diversity of HLA: functional and medical implications. Paris: EDK; 1997. p. 584–95.
- 39 Lee KW, Cho HC. Reverse-SSO hybridization provides an accurate and simple HLA-DR typing: a comparative study with HLA-DR serologic typing. J Korean Med Sci 1994; 9: 414–26.
- 40 Fernandez-Vina MA, Bignon JD. Primers and oligonucleotide probes (SSOP) used for DNA typing of HLA class II alleles. In: D Charron, editor. Genetic diversity of HLA: functional and medical implications. Paris: EDK; 1997. p. 596–632.
- 41 Kotsch K, Wehling J, Blasczyk R. Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: sequencing based typing of HLA-DRB genes. Tissue Antigens 1999; 53: 486–97.
- 42 Blasczyk R. Sequence-based typing for HLA-DRB1 and DRB3/4/5 separating alleles. In: MG Tilanus, JA Hansen, CK Hurley, editors. IHWG technical manual. Seattle: International Histocompatibility Working Group; 2000. p. TM10C1–10.
- 43 Payami H, Joe S, Farid NR, Stenszky V, Chan SH, Yeo PP, et al. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 1989; 45: 541–6.
- 44 Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57: 289–300.
- 45 Astorga GP, Williams RC Jr. Altered reactivity in mixed lymphocyte culture of lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum 1969; 12: 547–54.
- 46 Crilly A, Maiden N, Capell HA, Madhok R. Genotyping for disease associated HLA DRβ1 alleles and the need for early joint surgery in rheumatoid arthritis: a quantitative evaluation. Ann Rheum Dis 1999; 58: 114–7.
- 47 Fries JF, Wolfe F, Apple R, Erlich H, Bugawan T, Holmes T, et al. HLA–DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias. Arthritis Rheum 2002; 46: 2320–9.
- 48 Meyer JM, Han J, Singh R, Moxley G. Sex influences on the penetrance of HLA shared-epitope genotypes for rheumatoid arthritis. Am J Hum Genet 1996; 58: 371–83.
- 49 Del Rincon I, Battafarano DF, Arroyo RA, Murphy FT, Escalante A. Heterogeneity between men and women in the influence of the HLA–DRB1 shared epitope on the clinical expression of rheumatoid arthritis. Arthritis Rheum 2002; 46: 1480–8.
- 50 Jaraquemada D, Ollier W, Awad J, Young A, Silman A, Roitt IM, et al. HLA and rheumatoid arthritis: a combined analysis of 440 British patients. Ann Rheum Dis 1986; 45: 627–36.
- 51 Koh WH, Chan SH, Lin YN, Boey ML. Association of HLA-DRB1*0405 with extraarticular manifestations and erosions in Singaporean Chinese with rheumatoid arthritis. J Rheumatol 1997; 24: 629–32.
- 52 Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994; 56: 389–466.
- 53 Jawaheer D, Li W, Graham RR, Chen W, Damle A, Xiao X, et al. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet 2002; 71: 585–94.
- 54 MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A. HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol 1995; 22: 1032–6.
- 55 Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996; 59: 1134–48.
- 56 Park YS, She JX, Noble JA, Erlich HA, Eisenbarth GS. Transracial evidence for the influence of the homologous HLA DR-DQ haplotype on transmission of HLA DR4 haplotypes to diabetic children. Tissue Antigens 2001; 57: 185–91.
- 57 Thursz MR, Thomas HC, Greenwood BM, Hill AV. Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet 1997; 17: 11–2.
- 58 Van der Horst-Bruinsma IE, Visser H, Hazes JM, Breedveld FC, Verduyn W, Schreuder GM, et al. HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum Immunol 1999; 60: 152–8.
- 59 Wagner U, Kaltenhauser S, Pierer M, Seidel W, Troltzsch M, Hantzschel H, et al. Prospective analysis of the impact of HLA-DR and -DQ on joint destruction in recent-onset rheumatoid arthritis. Rheumatology (Oxford) 2003; 42: 553–62.